XANO acquires leading Pharma/Industry 4.0 production software specialist
XANO has today signed an agreement, via a subsidiary, to acquire all the shares in CIM Industrial Systems A/S with subsidiary, located in Aarhus, Copenhagen and Fredericia, Denmark.
CIM is a leading production software specialist. Based on own frameworks and products, CIM provides end-to-end production software solutions within Industrial IoT, Track & Trace/Serialisation, Machine Vision and Test & Measurement, as well as related custom work. CIM’s solutions enable their customers to make business critical decisions based on reliable data. Customers include blue-chip pharmaceutical and infrastructure companies.
CIM employs approx. 50 people, of which the majority has an engineering background. Sales totalled DKK 56 million in 2020. The company is in an expanding phase and expects a growth of approx. 15% in 2021, related to both existing and new market segments.
CIM’s industrial software products and development resources will complement and complete existing automation operations within the XANO Industrial Solutions business unit. The acquisition adds technical software expertise and brings access to new market segments. There are positive development opportunities for the business concept internationally and many of CIM's services are directly applicable to the proprietary systems within the business unit. With common resources, the business unit's companies now have the potential to provide complete turnkey solutions with its own added software intelligence and with that the strength to carry out extensive and complex automation assignments. CIM’s products and services may also be offered to customer in the Group’s other business units.
Consolidation will be effective as of 31 May 2021. The acquired units are expected to have a marginal positive impact on XANO’s earnings per share.
Documents
Subscribe
Subscribe to press releases
Thank you, we have received your application.
An error occurred while sending the subscription. Please try again later.